In the context of NMPA registration (National Medical Products Administration) for invasive blood pressure monitoring devices in China, the technical requirements for clinical evaluation focus on demonstrating the device's safety, efficacy, and clinical performance through rigorous evaluation methods. Here are the key technical requirements for clinical evaluation:

Clinical Evaluation Requirements:

1. Clinical Data Collection:

   • Gather comprehensive clinical data from various sources, including clinical trials, observational studies, literature reviews, and post-market surveillance.
   • Ensure the data collection methods adhere to Good Clinical Practice (GCP) guidelines and are conducted by qualified investigators.

2. Clinical Study Design:

   • Design clinical studies (e.g., randomized controlled trials, observational studies) with clear objectives, inclusion/exclusion criteria, endpoints, and statistical analysis plans.
   • Specify patient demographics, treatment protocols, device usage instructions, and control procedures in the study design.

3. Endpoint Definitions:

   • Define primary and secondary endpoints that measure the device's safety, efficacy, and clinical performance outcomes.
   • Endpoints may include parameters such as accuracy of blood pressure measurements, device reliability, patient comfort, and usability.

4. Comparative Analysis:

   • Conduct comparative analysis against relevant benchmarks or predicate devices to establish the device's superiority, non-inferiority, or equivalence in clinical performance.

5. Risk Assessment and Mitigation:

   • Perform risk assessment according to ISO 14971 standards to identify potential hazards associated with the device and implement risk mitigation measures.
   • Assess the impact of identified risks on patient safety and clinical outcomes.

6. Biocompatibility and Safety:

   • Ensure the device’s biocompatibility through testing according to ISO 10993 standards, demonstrating its compatibility with human tissues and minimizing risks of adverse reactions.

7. Clinical Study Reports:

   • Prepare comprehensive clinical study reports summarizing study objectives, methods, data analysis, results, conclusions, and implications for clinical practice.
   • Include statistical analyses, tables, and graphs illustrating clinical data and outcomes.

8. Ethical Considerations:

   • Obtain approval from independent ethics committees (Institutional Review Board - IRB) at each trial site to ensure compliance with ethical principles, patient rights, and participant confidentiality.

9. Post-Market Surveillance (PMS):

   • Establish a post-market surveillance plan to monitor the device's ongoing safety and performance in real-world clinical settings.
   • Report adverse events, device malfunctions, and unexpected outcomes to regulatory authorities as required.

Contact Us：

Whatsapp or Wechat：+86 15816864648；email address：hito.lin@grzan.cn